Skip to content

PTHS PTHS Shares (Diluted)

Shares (Diluted) at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
15M-2.0%
Journey Medical Corporation logo
Journey Medical CorporationDERM
27.3M+20.8%
Opko Health logo
Opko HealthOPK
758.9M+13.0%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
60.2M+11.3%
Theravance Biopharma logo
Theravance BiopharmaTBPH
51.3M+3.2%
HRO
HarrowHROW
37.2M+3.9%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's shares (diluted)?
PTHS (PTHS) reported shares (diluted) of 3.3M in Q1 2026.
How has PTHS's shares (diluted) changed year-over-year?
PTHS's shares (diluted) increased by 440.3% year-over-year, from 612.9K to 3.3M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.